These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7611721)

  • 1. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy.
    Gao WQ; Dybdal N; Shinsky N; Murnane A; Schmelzer C; Siegel M; Keller G; Hefti F; Phillips HS; Winslow JW
    Ann Neurol; 1995 Jul; 38(1):30-7. PubMed ID: 7611721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.
    Mizisin AP; Calcutt NA; Tomlinson DR; Gallagher A; Fernyhough P
    J Peripher Nerv Syst; 1999; 4(3-4):211-21. PubMed ID: 10642089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve growth factor prevents experimental cisplatin neuropathy.
    Apfel SC; Arezzo JC; Lipson L; Kessler JA
    Ann Neurol; 1992 Jan; 31(1):76-80. PubMed ID: 1543351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy.
    Chattopadhyay M; Goss J; Wolfe D; Goins WC; Huang S; Glorioso JC; Mata M; Fink DJ
    Brain; 2004 Apr; 127(Pt 4):929-39. PubMed ID: 14749293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats.
    Tredici G; Braga M; Nicolini G; Miloso M; Marmiroli P; Schenone A; Nobbio L; Frattola L; Cavaletti G
    Exp Neurol; 1999 Oct; 159(2):551-8. PubMed ID: 10506527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar enlargement, nuclear eccentricity and altered cell body immunostaining characteristics of large-sized sensory neurons following treatment of rats with paclitaxel.
    Jamieson SM; Liu JJ; Connor B; Dragunow M; McKeage MJ
    Neurotoxicology; 2007 Nov; 28(6):1092-8. PubMed ID: 17686523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss.
    Jamieson SM; Liu J; Connor B; McKeage MJ
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):391-9. PubMed ID: 15887017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
    Meijer C; de Vries EG; Marmiroli P; Tredici G; Frattola L; Cavaletti G
    Neurotoxicology; 1999 Dec; 20(6):883-7. PubMed ID: 10693969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.
    Krarup-Hansen A; Helweg-Larsen S; Schmalbruch H; Rørth M; Krarup C
    Brain; 2007 Apr; 130(Pt 4):1076-88. PubMed ID: 17301082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
    Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
    Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophin-3 administration alters neurotrophin, neurotrophin receptor and nestin mRNA expression in rat dorsal root ganglia following axotomy.
    Kuo LT; Groves MJ; Scaravilli F; Sugden D; An SF
    Neuroscience; 2007 Jun; 147(2):491-507. PubMed ID: 17532148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.
    Cavaletti G; Petruccioli MG; Marmiroli P; Rigolio R; Galbiati S; Zoia C; Ferrarese C; Tagliabue E; Dolci C; Bayssas M; Griffon Etienne G; Tredici G
    Anticancer Res; 2002; 22(6C):4199-204. PubMed ID: 12553056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective interactions in rats between paclitaxel and cisplatin.
    McKeage MJ; Haddad GG; Ding L; Galettis P; Screnci D; Zhuang L; Baguley BC
    Oncol Res; 1999; 11(6):287-93. PubMed ID: 10691031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study.
    Rodriguez-Menendez V; Gilardini A; Bossi M; Canta A; Oggioni N; Carozzi V; Tremolizzo L; Cavaletti G
    Anticancer Res; 2008; 28(1A):335-42. PubMed ID: 18383866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.
    Carozzi VA; Canta A; Oggioni N; Sala B; Chiorazzi A; Meregalli C; Bossi M; Marmiroli P; Cavaletti G
    Exp Neurol; 2010 Dec; 226(2):301-9. PubMed ID: 20832406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of neurotrophin-3 during early development of the peripheral nervous system.
    Ockel M; von Schack D; Schröpel A; Dechant G; Lewin GR; Barde YA
    Philos Trans R Soc Lond B Biol Sci; 1996 Mar; 351(1338):383-7. PubMed ID: 8730775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sural nerve conduction study in the rat: a new technique for studying experimental neuropathies.
    deJesus CP; Towfighi J; Snyder DR
    Muscle Nerve; 1978; 1(2):162-7. PubMed ID: 220531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
    Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
    Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol.
    Cavaletti G; Tredici G; Braga M; Tazzari S
    Exp Neurol; 1995 May; 133(1):64-72. PubMed ID: 7601264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuropathy caused by cisplatin. Clinical, electrophysiological and morphological study].
    Gastaut JL; Pellissier JF
    Rev Neurol (Paris); 1985; 141(10):614-26. PubMed ID: 3003868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.